Your browser doesn't support javascript.
loading
[Type I interferonopathies]. / Interféronopathies de type I.
Munoz, J; Marque, M; Dandurand, M; Meunier, L; Crow, Y-J; Bessis, D.
Afiliação
  • Munoz J; Département de dermatologie, hôpital Caremeau, CHRU de Nîmes, 4, rue du Professeur-Debré, 30029 Nîmes, France.
  • Marque M; Département de dermatologie, hôpital Caremeau, CHRU de Nîmes, 4, rue du Professeur-Debré, 30029 Nîmes, France.
  • Dandurand M; Département de dermatologie, hôpital Caremeau, CHRU de Nîmes, 4, rue du Professeur-Debré, 30029 Nîmes, France.
  • Meunier L; Département de dermatologie, hôpital Caremeau, CHRU de Nîmes, 4, rue du Professeur-Debré, 30029 Nîmes, France; UMR CNRS 5247, institut des biomolécules Max-Mousseron, faculté de pharmacie, 15, avenue Charles-Flahault, BP 14491, 34093 Montpellier cedex 05, France.
  • Crow YJ; Laboratoire de neurogénétique et de neuro-inflammation, institut Imagine, hôpital Necker-Enfants-Malades, université Paris Descartes, 24, boulevard du Montparnasse, 75015 Paris, France; Manchester centre for genomic medicine, institute of human development, faculty of medical and human sciences, Man
  • Bessis D; Département de dermatologie, hôpital Saint-Eloi, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France; Université Montpellier 1, 163, rue Auguste-Broussonnet, 34090 Montpellier, France; Inserm U1058, UFR de pharmacie, 15, avenue Charles-Flahaut, 34093 Montpellier cedex
Ann Dermatol Venereol ; 142(11): 653-63, 2015 Nov.
Article em Fr | MEDLINE | ID: mdl-26363997
ABSTRACT
Type I interferonopathies are a group of Mendelian disorders characterized by a common physiopathology the up-regulation of type I interferons. To date, interferonopathies include Aicardi-Goutières syndrome, familial chilblain lupus, spondyenchondromatosis, PRoteasome-associated auto-inflammatory syndrome (PRAAS) and Singleton-Merten syndrome. These diseases present phenotypic overlap including cutaneous features like chilblain lupus, that can be inaugural or present within the first months of life. This novel set of inborn errors of immunity is evolving rapidly, with recognition of new diseases and genes. Recent and improved understanding of the physiopathology of overexpression of type I interferons has allowed the development of targeted therapies, currently being evaluated, like Janus-kinases or reverse transcriptase inhibitors.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Doenças Autoimunes do Sistema Nervoso / Malformações do Sistema Nervoso Limite: Humans Idioma: Fr Revista: Ann Dermatol Venereol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Doenças Autoimunes do Sistema Nervoso / Malformações do Sistema Nervoso Limite: Humans Idioma: Fr Revista: Ann Dermatol Venereol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França